MohanSuntharalingamMD

Radiation Oncology • Baltimore, MD

Professor of Radiation Oncology, University MD School of Medicine

Join to view full profile

Dr. Suntharalingam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Suntharalingam's full profile

Already have an account?

Office
22 S Greene St
Gudelsky Basement
Baltimore, MD 21201
Phone+1 410-328-3037

Fax+1 410-328-3040

Education & Training

Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 1990 - 1991
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990

Certifications & Licensure

MD State Medical License 1995 - 2025
PA State Medical License 1993 - 1994
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Join now to see all

Clinical Trials

Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) Start of enrollment: 2002 May 01
Completed
Phase 2
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophage...
Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski
Quality of Life Research. 2024-10-01
4 citations
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Ran...
Christopher L Hallemeier, Jennifer Moughan, Michael G Haddock, Arnold M Herskovic, Bruce D Minsky
JAMA Network Open. 2023-04-03
4 citations
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.
Musaddiq J. Awan, Haley Gittleman, Jill S. Barnholtz-Sloan, Mitchell Machtay, Phuc Felix Nguyen-Tan
Oral Oncology. 2021-05-01

Press Mentions

Groundbreaking Celebration for University of Maryland Shore Regional Medical Center Marks Major Milestone in Evolution of Health Care on Maryland’s Eastern ShoreOctober 22nd, 2024
A Buggy CrowdStrike Update Caused a Global Computer Meltdown. Here’s How It Affected the UM Medical SystemAugust 19th, 2024
UMBWMC Ranked #5 Hospital in Area by US News & World ReportJuly 22nd, 2024
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member